Search research articles
Contact Us
Filters
Showing results (121-130 of 785) with videos related to
Page
of 79
Sort By:
Kidney & Blood Pressure Research
|
July 30, 2003
Diabetic nephropathy: an inherited disease or just a diabetic complication?
Mario Berger, Detlev Mönks, Christoph Wanner, et al.
MMW Fortschritte Der Medizin
|
June 10, 2014
[The diabetic patient with nephropathy]
Christiane Drechsler, Andreas Schneider, Kay-Renke Schmidt, et al.
European Heart Journal
|
August 21, 2015
Lowering cholesterol in chronic kidney disease: is it safe and effective?
Muh Geot Wong, Christoph Wanner, John Knight, et al.
Atherosclerosis
|
November 18, 2005
Impact of oxidized low density lipoprotein on vascular cells
Jan Galle, Thomas Hansen-Hagge, Christoph Wanner, et al.
Atherosclerosis
|
October 19, 2021
Statin initiation in dialysis patients: The hardship of non-prescription
Manfred Hecking, Angelo Karaboyas, Gerit-Holger Schernthaner, et al.
Kidney International. Supplement
|
April 16, 2003
Genetic aspects of diabetic nephropathy
Tom H Lindner, Detlev Mönks, Christoph Wanner, et al.
Kidney International
|
June 26, 2002
Advanced glycation end products and mortality in hemodialysis patients
Susanne B Schwedler, Thomas Metzger, Reinhard Schinzel, et al.
Journal of the American Society of Nephrology : JASN
|
September 27, 2000
Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells
Alexandra Heinloth, Kathrin Heermeier, Ulrike Raff, et al.
Lancet (London, England)
|
May 4, 2010
Enzyme replacement therapy for Fabry's disease
Stephen Waldek, Dominique P Germain, Christoph Wanner, et al.
Biochimica Et Biophysica Acta
|
September 13, 2005
Beta(2)-microglobulin removal by extracorporeal renal replacement therapies
Detlef H Krieter, Horst-Dieter Lemke, Bernard Canaud, et al.
Page
of 79
Search research articles
Search
Showing results (121-130 of 785) with videos related to
Sort By:
Page
of 79
Kidney & Blood Pressure Research
|
July 30, 2003
Diabetic nephropathy: an inherited disease or just a diabetic complication?
Mario Berger, Detlev Mönks, Christoph Wanner, et al.
MMW Fortschritte Der Medizin
|
June 10, 2014
[The diabetic patient with nephropathy]
Christiane Drechsler, Andreas Schneider, Kay-Renke Schmidt, et al.
European Heart Journal
|
August 21, 2015
Lowering cholesterol in chronic kidney disease: is it safe and effective?
Muh Geot Wong, Christoph Wanner, John Knight, et al.
Atherosclerosis
|
November 18, 2005
Impact of oxidized low density lipoprotein on vascular cells
Jan Galle, Thomas Hansen-Hagge, Christoph Wanner, et al.
Atherosclerosis
|
October 19, 2021
Statin initiation in dialysis patients: The hardship of non-prescription
Manfred Hecking, Angelo Karaboyas, Gerit-Holger Schernthaner, et al.
Kidney International. Supplement
|
April 16, 2003
Genetic aspects of diabetic nephropathy
Tom H Lindner, Detlev Mönks, Christoph Wanner, et al.
Kidney International
|
June 26, 2002
Advanced glycation end products and mortality in hemodialysis patients
Susanne B Schwedler, Thomas Metzger, Reinhard Schinzel, et al.
Journal of the American Society of Nephrology : JASN
|
September 27, 2000
Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells
Alexandra Heinloth, Kathrin Heermeier, Ulrike Raff, et al.
Lancet (London, England)
|
May 4, 2010
Enzyme replacement therapy for Fabry's disease
Stephen Waldek, Dominique P Germain, Christoph Wanner, et al.
Biochimica Et Biophysica Acta
|
September 13, 2005
Beta(2)-microglobulin removal by extracorporeal renal replacement therapies
Detlef H Krieter, Horst-Dieter Lemke, Bernard Canaud, et al.
Page
of 79